Genzyme of Cambridge, Massachusetts, faces millions in lost revenue from its top-selling specialty drugs Cerezyme and Fabrazyme as result of a viral contamination at its Allston, Massachusetts plant.

Although Genzyme has no equity stake in Osiris, which will keep all US and Canadian rights to its MSC products and indications, the Cambridge, Massachusetts–based company does get commercial ...